Needham & Company Comments on Sector Implications Amid Medtronic (MDT)/Covidien (COV) Megadeal
Tweet Send to a Friend
Needham & Company analyst Mike Matson comments on the sector implications amid Medtronic's (NYSE: MDT) $42.9 billion deal to acquire ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
